Intervention

Quetiapine XR

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 13 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials13

Recruiting0

Common conditions13

Lead sponsors shown9

Clinical trials

13 shown

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant TherapyNCT04513912 · 2020-09-15

COMPLETED

A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant TherapyNCT03321526 · 2017-12-12

COMPLETED

The Quietude Study: Quetiapine Use for Agitated DepressionNCT01363310 · 2010-10-01

TERMINATED

Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute PsychiatryNCT00986167 · 2009-10-01

UNKNOWN

Quetiapine XR in Schizophrenic PatientsNCT01071135 · 2009-09-01

TERMINATED

Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic SchizophreniaNCT00789698 · 2008-12-01

COMPLETED

Clinical Benefits of Seroquel XR in Anxiety DisorderNCT01672554 · 2008-12-01

UNKNOWN

Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD PatientsNCT00789854 · 2008-11-01

COMPLETED

Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.NCT00790192 · 2008-10-01

COMPLETED

Schizophrenic Patients in Integrated CareNCT00681629 · 2008-07-01

TERMINATED

Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety DisorderNCT00868374 · 2008-06-01

TERMINATED

Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to RisperidoneNCT00600756 · 2008-01-01

COMPLETED

The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar DepressionNCT00517387 · 2007-09-01

COMPLETED

Common conditions

Schizophrenia5 Depressive Disorder, Major2 Major Depressive Disorder2 Anxiety1 Chronic Schizophrenia1 Depression With Prominent Agitation1 Generalized Anxiety Disorder1 Psychosis1 Schizoaffective Disorder1 Schizophrenic Disorders1 Schizophreniform Disorder1 Treatment Resistant Depression1 Unipolar Depression1

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

schizophrenia5 major depressive disorder3 anxiety1 generalized anxiety disorder1 psychotic disorder1 schizoaffective disorder1 schizophreniform disorder1

Leading sponsors

AstraZeneca 3 Janssen Research & Development, LLC 2 Sumitomo Pharma America, Inc. 2 Bayside Health 1 Corporation de Recherche en Neuropsycho Pharmacologie de Quebec 1 Hannover Medical School 1 Keming Gao 1 Physicians Research And Education Network 1 University of British Columbia 1

Trial status mix

COMPLETED7

TERMINATED4

UNKNOWN2

Phase mix

PHASE310

PHASE42

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.